Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001332936 | SCV001525380 | uncertain significance | Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart | 2019-10-21 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Ambry Genetics | RCV004960796 | SCV005487287 | uncertain significance | Inborn genetic diseases | 2024-10-30 | criteria provided, single submitter | clinical testing | The c.2519C>T (p.S840F) alteration is located in exon 19 (coding exon 17) of the RERE gene. This alteration results from a C to T substitution at nucleotide position 2519, causing the serine (S) at amino acid position 840 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |